Project Grant SB1HL182470
Award Date 9/17/25
Completion Date 8/31/26
Dollars Obligated $500K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02109, USA
Similar Awards
- This federal Project Grant award from the National Heart Lung and Blood Institute under CFDA Program 93.837 - Cardiovascular Diseases Research provides $306,872 to Airalux Medical, Inc. to develop a digital incentive spirometry device. The goal is to improve patient adherence and clinical workflows for preventing post-surgical lung complications, which occur in 1 in 20 patients undergoing an overnight hospital stay. The device uses sensors and software to automatically track patient usage and...
- This Project Grant award of $371,021 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of a continuous respiratory monitoring platform to better classify apnea of prematurity (AOP) in premature newborns. The primary products to be delivered are: 1) a multimodal system and machine learning model to accurately detect and classify the major types of AOP (central, obstructive, and mixed); and 2) an optimized prototype system...
- This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
- This Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), provides $256,000 to Colabs, Inc. to develop an automated airway and ventilator system that eliminates human operator variability during cardiopulmonary resuscitation (CPR). The system aims to reliably place an airway tube for ventilation, synchronize air delivery with chest compressions, and enable cardiac defibrillation at lower voltages through an electrode...
- The National Science Foundation (NSF) awarded Compact Medical Inc., a for-profit medical device manufacturer, a $999,931 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The funding supports the development and testing of a novel, adjustable bag-valve-mask (BVM) resuscitator device that allows emergency providers to deliver customized air volumes and pressures based on patient body size. This advanced resuscitator aims to address issues with...
- Compact Medical Inc. received a $255,925 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop a novel respiratory bag-valve-mask resuscitator. The grant was awarded on August 15, 2021 under the NSF's Engineering program (CFDA #47.041) and will support product development activities through February 28, 2022. The Engineering program seeks to foster innovation in engineering research and education to improve quality of life and economic strength....
- This Project Grant award of $807,067.00 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will support a study to pioneer the quantitative documentation of human respiratory kinematic profiles. The study aims to address a critical gap in contemporary physiological monitoring - the inability to quantify labored breathing, which contains vital prognostic information not captured by conventional monitoring. Building on a recent innovation called ARK...
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $761,599.00 to Trustees of Boston University, doing business as Boston University Medical Campus, to conduct research on quantifying uncertainty to inform time-limited trials of invasive mechanical ventilation. The research aims to fill critical knowledge gaps around clinicians' ability to recognize prognostic uncertainty, optimal durations for time-limited trials,...
- This $500,000 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of the Hemotago HATS-OFF (Hemotag Assessment for Short-Term Outcomes of Heart Failure) technology by Aventusoft LLC, a small disadvantaged business in Boca Raton, Florida. The HATS-OFF system provides a non-invasive, at-home method for long-term monitoring of heart failure patients to detect decompensation early and enable timely therapy...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is focused on commercializing a novel Head-Up Position (HUP) CPR system to improve survival rates for out-of-hospital and in-hospital sudden cardiac arrest (SCA) patients. The $498,453 award supports Resuscitation Innovations LLC's efforts to optimize, manufacture, and validate the refined Elegard 3.0 device, which enables HUP CPR. This...